Krilogy Financial LLC Bluebird Bio, Inc. Transaction History

Krilogy Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $5,910 - $9,326	-100 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $8,886 - $11,749	100 New	100 $15,000
Q2 2018 Aug 15, 2018	SELL	$99.64 - $127.59 $9,964 - $12,759	-100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $10,580 - $15,094	100 New	100 $17,000
Q3 2017 Nov 15, 2017	SELL	$57.74 - $91.42 $5,774 - $9,142	-100 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	100	100 $11,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.